Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-2-14
pubmed:abstractText
The goal of the present investigation was to test the hypothesis that types 1, 2, and 3 iodothyronine selenodeiodinases (D1, D2, and D3) can form homodimers. The strategy included transient coexpression of wild-type (wt) deiodinases (target), and FLAG-tagged alanine or cysteine mutants (bait) in human embryonic kidney epithelial cells. SDS-PAGE of the immunoprecipitation pellet of (75)Se-labeled cell lysates using anti-FLAG antibody revealed bands of the correct sizes for the respective wt enzymes, which corresponded to approximately 2-5% of the total deiodinase protein in the cell lysate. Western blot analysis with anti-FLAG antibody of lysates of cells transiently expressing individual FLAG-tagged-cysteine deiodinases revealed specific monomeric bands for each deiodinase and additional minor bands of relative molecular mass (M(r)) of 55,000 for D1, M(r) 62,000 for D2, and M(r) 65,000 for D3, which were eliminated by 100 mM dithiothreitol at 100 C. Anti-FLAG antibody immunodepleted 10% of D1 and 38% of D2 activity from lysates of cells coexpressing inactive FLAG-tagged Ala mutants and the respective wt enzymes (D1 or D2) but failed to immunodeplete wtD3 activity. D1 or D2 activities were present in these respective pellets. We conclude 1) that overexpressed selenodeiodinases can homodimerize probably through disulfide bridges; and 2) at least for D1 and D2, monomeric forms are catalytically active, demonstrating that only one wt monomer partner is required for catalytic activity of these two deiodinases.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0013-7227
pubmed:author
pubmed:issnType
Print
pubmed:volume
144
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
937-46
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:12586771-Blotting, Western, pubmed-meshheading:12586771-Catalysis, pubmed-meshheading:12586771-Cell Line, pubmed-meshheading:12586771-Dimerization, pubmed-meshheading:12586771-Disulfides, pubmed-meshheading:12586771-Dithiothreitol, pubmed-meshheading:12586771-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:12586771-Gene Expression, pubmed-meshheading:12586771-Humans, pubmed-meshheading:12586771-Immunosorbent Techniques, pubmed-meshheading:12586771-Iodide Peroxidase, pubmed-meshheading:12586771-Isotope Labeling, pubmed-meshheading:12586771-Molecular Weight, pubmed-meshheading:12586771-Mutagenesis, Site-Directed, pubmed-meshheading:12586771-Mutation, pubmed-meshheading:12586771-Recombinant Proteins, pubmed-meshheading:12586771-Selenium Radioisotopes, pubmed-meshheading:12586771-Structure-Activity Relationship, pubmed-meshheading:12586771-Transfection
pubmed:year
2003
pubmed:articleTitle
In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases.
pubmed:affiliation
Thyroid Section, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.